SCHEMBL30830577

SCHEMBL30830577

COC(=O)c1ccc([C@H]2C[C@@H](N)CN(C)C2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.49
▸ HSD17B10 Q99714 3/20 0.49
▸ KDM4E B2RXH2 3/20 0.49
▸ GAA P10253 3/20 0.49
▸ TSHR P16473 2/20 0.49
▸ HPGD P15428 2/20 0.49
▸ CASP1 P29466 2/20 0.49
▸ CASP7 P55210 2/20 0.49
▸ ATM Q13315 2/20 0.49
▸ GRIN2B Q13224 1/20 0.44
▸ HTT P42858 2/20 0.44
▸ GLA P06280 1/20 0.43
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ MAPT P10636 1/20 0.41
▸ KDM1A O60341 2/20 0.40
▸ MAOA P21397 2/20 0.40
▸ KDM1B Q8NB78 2/20 0.40
▸ RCOR1 Q9UKL0 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25004299 0.87 HSD17B10 (0.54) ALDH1A1HSD17B10KDM4EGAATSHR
SCHEMBL27950455 0.84 ALDH1A1 (0.54) ALDH1A1HSD17B10KDM4EGAATSHR
SCHEMBL27314351 0.78 KDM1A (0.50) ALDH1A1GAAKDM1AMAOAKMT2A
SCHEMBL27314354 0.78 KDM1A (0.50) ALDH1A1GAAKDM1AMAOAKMT2A
SCHEMBL21221586 0.77 ALDH1A1 (0.51) ALDH1A1HSD17B10KDM4EGAATSHR
SCHEMBL38657721 0.76 ALDH1A1 (0.52) ALDH1A1HSD17B10KDM4EGAATSHR
SCHEMBL31091756 0.75 KDM4D (0.45) ALDH1A1HSD17B10KDM4EGAATSHR
SCHEMBL30831046 0.75 KDM4D (0.45) ALDH1A1HSD17B10KDM4EGAATSHR
Hydrochloric Acid SCHEMBL32677527 0.75 ALDH1A1 (0.51) ALDH1A1HSD17B10KDM4EGAATSHR
SCHEMBL63894 0.75 HDAC3 (0.54) ALDH1A1HSD17B10KDM4EGAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024220843-A1 TECHNOLOGIES TARGETING CELL STATES AURON THERAPEUTICS, INC. (US) 2024-10-24 — — WO disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback